Published in J Physiol on October 01, 2011
Molecular networks of human muscle adaptation to exercise and age. PLoS Genet (2013) 1.14
Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22
Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol (2008) 8.51
Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol (1985) (2010) 2.74
High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol (2009) 2.21
Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial. PLoS One (2009) 1.68
Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil (2003) 1.60
Ten questions about systems biology. J Physiol (2011) 1.36
Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays. Leukemia (2004) 1.19
Drug discovery: Predicting promiscuity. Nature (2009) 1.16
Brain-derived neurotrophic factor predicts mortality risk in older women. J Am Geriatr Soc (2009) 1.00
Recruited vs. nonrecruited molecular signatures of brown, "brite," and white adipose tissues. Am J Physiol Endocrinol Metab (2011) 2.78
High responders to resistance exercise training demonstrate differential regulation of skeletal muscle microRNA expression. J Appl Physiol (1985) (2010) 2.25
Extremely short duration high intensity interval training substantially improves insulin action in young healthy males. BMC Endocr Disord (2009) 2.09
A transcriptional map of the impact of endurance exercise training on skeletal muscle phenotype. J Appl Physiol (1985) (2010) 2.07
Considerations when using the significance analysis of microarrays (SAM) algorithm. BMC Bioinformatics (2005) 1.89
Distinct expression of muscle-specific microRNAs (myomirs) in brown adipocytes. J Cell Physiol (2009) 1.67
Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med (2010) 1.64
Dysregulation of mitochondrial dynamics and the muscle transcriptome in ICU patients suffering from sepsis induced multiple organ failure. PLoS One (2008) 1.52
Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. PLoS One (2009) 1.46
Thermogenically competent nonadrenergic recruitment in brown preadipocytes by a PPARgamma agonist. Am J Physiol Endocrinol Metab (2008) 1.43
The importance of brown adipose tissue. N Engl J Med (2009) 1.31
Systematic analysis of adaptations in aerobic capacity and submaximal energy metabolism provides a unique insight into determinants of human aerobic performance. J Appl Physiol (1985) (2009) 1.31
Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration? FASEB J (2007) 1.19
Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med (2010) 1.18
Molecular networks of human muscle adaptation to exercise and age. PLoS Genet (2013) 1.14
The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function. BMC Genomics (2007) 1.10
Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocr Disord (2011) 1.08
Genomics and genetics in the biology of adaptation to exercise. Compr Physiol (2011) 1.02
Resistance to aerobic exercise training causes metabolic dysfunction and reveals novel exercise-regulated signaling networks. Diabetes (2013) 1.02
An essential role for Tbx15 in the differentiation of brown and "brite" but not white adipocytes. Am J Physiol Endocrinol Metab (2012) 1.00
Chronic treatment with the beta(2)-adrenoceptor agonist prodrug BRL-47672 impairs rat skeletal muscle function by inducing a comprehensive shift to a faster muscle phenotype. J Pharmacol Exp Ther (2006) 0.96
Time-series transcriptional profiling yields new perspectives on susceptibility to murine osteoarthritis. Arthritis Rheum (2012) 0.96
Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle. Diabetes (2005) 0.92
Integrative pathway analysis of a genome-wide association study of (V)O(2max) response to exercise training. J Appl Physiol (1985) (2013) 0.91
The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction. Diabetes (2006) 0.90
Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies. Clin Cancer Res (2012) 0.89
Loss of neuronatin promotes "browning" of primary mouse adipocytes while reducing Glut1-mediated glucose disposal. Am J Physiol Endocrinol Metab (2013) 0.89
Commentary on viewpoint: Perspective on the future use of genomics in exercise prescription. J Appl Physiol (1985) (2008) 0.85
Focal adhesion kinase is required for IGF-I-mediated growth of skeletal muscle cells via a TSC2/mTOR/S6K1-associated pathway. Am J Physiol Endocrinol Metab (2013) 0.84
Metabolic adaptations to repeated periods of contraction with reduced blood flow in canine skeletal muscle. BMC Physiol (2005) 0.81
Using functional genomics to study PINK1 and metabolic physiology. Methods Enzymol (2009) 0.79
Modulation of microRNAs during exercise and disease in human skeletal muscle. Exerc Sport Sci Rev (2011) 0.78
Can we "switch" the emphasis please? J Appl Physiol (1985) (2002) 0.75
Chasing the "ghost" of the acetyl group deficit. Med Sci Sports Exerc (2005) 0.75